Possible Biomarkers To Predict Response In Patients With Myelodysplastic Syndromes (MDS) Or Acute Myeloid Leukemia (AML) Treated With 5-Azacitidine

被引：0
|
作者：
Kuendgen, Andrea
Mueller-Thomas, Catharina
Urbaniak, Petra
Lauseker, Michael
Haferlach, Torsten
Alpermann, Tamara
Albuquerque, Andreia
Kohlmann, Alexander
Schnittger, Susanne
Hildebrandt, Barbara
Royer-Pokora, Brigitte
Gattermann, Norbert
Haas, Rainer
Germing, Ulrich
Goetze, Katharina
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2757.2757
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2757
引用
收藏
页数：2
相关论文
共 50 条
  • [31] End of Life (EOL) Metrics in Older Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)
    LoCastro, M.
    Baran, A. M.
    Liesveld, J.
    Becker, M. W.
    O'Dwyer, K. M.
    Husehon, E.
    Aljitawi, O. S.
    Baumgart, M.
    Snyder, E.
    Kluger, B.
    Mendler, J. H.
    Loh, K.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S285 - S285
  • [32] HEXAMETHYLENE BISACETAMIDE (HMBA) IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    ANDREEFF, M
    STONE, R
    YOUNG, C
    TONG, W
    ERVIN, T
    TAFURI, A
    KOLITZ, J
    RIFKIND, R
    KUFE, D
    MARKS, P
    LEUKEMIA, 1991, 5 (02) : 174 - 174
  • [33] Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following a diagnosis of breast cancer
    Padmanabhan, A.
    Block, A.
    Sait, S.
    Ford, L. A.
    O'Connor, T. L.
    Moysich, K. B.
    Baer, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Prognostic factors associated with progression of myelodysplastic syndromes (MDS) to acute myeloid leukemia (AML) in patients (pts) treated with decitabine.
    Fullmer, A.
    Borthakur, G.
    Kadia, T. M.
    Garcia-Manero, G.
    Jabbour, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Comprehensive Analysis of Safety: Rigosertib in 557 Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
    Garcia-Manero, Guillermo
    Fenaux, Pierre
    Al-Kali, Aref
    Navada, Shyamala C.
    Baer, Maria R.
    Raza, Azra
    Greenberg, Peter
    Kreuzer, Karl-Anton
    Hiwase, Devendra K.
    Roboz, Gail J.
    Santini, Valeria
    Platzbecker, Uwe
    Petrone, Michael E.
    Brownstein, Bernard
    Zbyszewski, Patrick Simon
    Maniar, Manoj
    Silverman, Lewis R.
    BLOOD, 2016, 128 (22)
  • [36] SIRPB1: BIOMARKER OF RESPONSE TO 5-AZACITIDINE TREATMENT IN MDS AND AML PATIENTS
    Guadagnuolo, V.
    Papayannidis, C.
    Iacobucci, I.
    Fontana, M. C.
    Simonetti, G.
    Padella, A.
    Imbrogno, E.
    Paolini, S.
    Abbenante, M. C.
    Parisi, S.
    Sartor, C.
    Ottaviani, E.
    Ferrari, A.
    Delledonne, M.
    Malagola, M.
    Fili, C.
    Russo, D.
    Cavo, M.
    Martinelli, G.
    HAEMATOLOGICA, 2015, 100 : 479 - 480
  • [37] MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIAS (AML) WITH MYELOFIBROSIS
    IMBERT, M
    NGUYEN, D
    SULTAN, C
    LEUKEMIA RESEARCH, 1992, 16 (01) : 51 - 54
  • [38] SIRPB1: BIOMARKER OF RESPONSE TO 5-AZACITIDINE TREATMENT IN MDS AND AML PATIENTS
    Guadagnuolo, V.
    Fontana, M. C.
    Papayannidis, C.
    Iacobucci, I.
    Padella, A.
    Simonetti, G.
    Imbrogno, E.
    Paolini, S.
    Abbenante, M.
    Parisi, S.
    Sartor, C.
    Ottaviani, E.
    Ferrari, A.
    Delledonne, M.
    Malagola, M.
    Fili, C.
    Russo, D.
    Cavo, M.
    Martinelli, G.
    HAEMATOLOGICA, 2015, 100 : 53 - 53
  • [39] IMPACT OF AZACITIDINE TREATMENT ON INFECTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA, MYELODYSPLASTIC SYNDROMES AND MYELODYSPLASTIC/MYELOPROLIFERATIVE SYNDROMES
    Villegas, C.
    Ortiz, S.
    Javier, K.
    Costa, S.
    Ivars, D.
    Collado, R.
    Lopez, M.
    Irene, L.
    Roig, M.
    Sanchez, M.
    Perez, P.
    Orero, M.
    HAEMATOLOGICA, 2016, 101 : 483 - 483
  • [40] Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5-azacitidine
    Radsak, Markus
    Platzbecker, Uwe
    Schmidt, Cornelia S.
    Hofmann, Wolf-Karsten
    Nolte, Florian
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (02) : 112 - 118
12345